{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T23:34:01Z","timestamp":1784763241719,"version":"3.55.0"},"reference-count":19,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,3,18]],"date-time":"2015-03-18T00:00:00Z","timestamp":1426636800000},"content-version":"vor","delay-in-days":76,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology Reports"],"published-print":{"date-parts":[[2015]]},"DOI":"10.1016\/j.toxrep.2015.03.006","type":"journal-article","created":{"date-parts":[[2015,4,5]],"date-time":"2015-04-05T02:30:18Z","timestamp":1428201018000},"page":"530-534","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"C","title":["CYP3A4 inhibition by Psoralea corylifolia and its major components in human recombinant enzyme, differentiated human hepatoma HuH-7 and HepaRG cells"],"prefix":"10.1016","volume":"2","author":[{"given":"Yitong","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas J.","family":"Flynn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.toxrep.2015.03.006_bib0005","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.fitote.2013.06.016","article-title":"Psoralea corylifolia L. (Buguchi) \u2013 folklore to modern evidence: review","volume":"90","author":"Chopra","year":"2013","journal-title":"Fitoterapia"},{"key":"10.1016\/j.toxrep.2015.03.006_bib0010","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1081\/CLT-200068863","article-title":"A case of acute cholestatic hepatitis associated with the seeds of Psoralea corylifolia (Boh-Gol-Zhee)","volume":"43","author":"Nam","year":"2005","journal-title":"Clin. Toxicol. (Phila.)"},{"key":"10.1016\/j.toxrep.2015.03.006_bib0015","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/S1665-2681(19)31777-6","article-title":"Severe hepatotoxicity by Indian ayurvedic herbal products: a structured causality assessment","volume":"8","author":"Teschke","year":"2009","journal-title":"Ann. Hepatol."},{"key":"10.1016\/j.toxrep.2015.03.006_bib0020","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1080\/15563650903059136","article-title":"Liver injury associated with the use of Fructus psoraleae (Bol-gol-zhee or Bu-gu-zhi) and its related proprietary medicine","volume":"47","author":"Cheung","year":"2009","journal-title":"Clin. Toxicol. (Phila.)"},{"key":"10.1016\/j.toxrep.2015.03.006_bib0025","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.det.2014.03.003","article-title":"UV-based therapy","volume":"32","author":"Totonchy","year":"2014","journal-title":"Dermatol. Clin."},{"key":"10.1016\/j.toxrep.2015.03.006_bib0030","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.toxlet.2011.11.030","article-title":"Furocoumarins affect hepatic cytochrome P450 and renal organic ion transporters in mice","volume":"209","author":"Wang","year":"2012","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.toxrep.2015.03.006_bib0035","doi-asserted-by":"crossref","first-page":"69","DOI":"10.4103\/0973-7847.65331","article-title":"Psoralea corylifolia Linn-Kushtanashini","volume":"4","author":"Khushboo","year":"2010","journal-title":"Pharmacogn. Rev."},{"key":"10.1016\/j.toxrep.2015.03.006_bib0040","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1080\/03602530701690374","article-title":"Drugs as CYP3A probes, inducers, and inhibitors","volume":"39","author":"Liu","year":"2007","journal-title":"Drug Metab. Rev."},{"key":"10.1016\/j.toxrep.2015.03.006_bib0045","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.pharmthera.2009.10.011","article-title":"Prediction of pharmacokinetic drug-drug interaction caused by changes in cytochrome P450 activity using in vivo information","volume":"125","author":"Hisaka","year":"2010","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.toxrep.2015.03.006_bib0050","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/apt.12109","article-title":"Review article: herbal and dietary supplement hepatotoxicity","volume":"37","author":"Bunchorntavakul","year":"2013","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.toxrep.2015.03.006_bib0055","doi-asserted-by":"crossref","first-page":"2330","DOI":"10.1124\/dmd.108.025494","article-title":"Prediction of human drug\u2013drug interactions from time-dependent inactivation of CYP3A4 in primary hepatocytes using a population-based simulator","volume":"37","author":"Xu","year":"2009","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.toxrep.2015.03.006_bib0060","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1080\/00498250802613620","article-title":"Characterization of increased drug metabolism activity in dimethyl sulfoxide (DMSO)-treated Huh7 hepatoma cells","volume":"39","author":"Choi","year":"2009","journal-title":"Xenobiotica"},{"key":"10.1016\/j.toxrep.2015.03.006_bib0065","doi-asserted-by":"crossref","first-page":"946","DOI":"10.2174\/1389200211314090002","article-title":"Hepatic cell lines for drug hepatotoxicity testing: limitations and strategies to upgrade their metabolic competence by gene engineering","volume":"14","author":"Donato","year":"2013","journal-title":"Curr. Drug Metab."},{"key":"10.1016\/j.toxrep.2015.03.006_bib0070","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.tiv.2009.03.008","article-title":"Functional expression, inhibition and induction of CYP enzymes in HepaRG cells","volume":"23","author":"Turpeinen","year":"2009","journal-title":"Toxicol. In Vitro"},{"key":"10.1016\/j.toxrep.2015.03.006_bib0075","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1124\/dmd.105.006759","article-title":"Expression of cytochromes P450, conjugating enzymes and nuclear receptors in human hepatoma HepaRG cells","volume":"34","author":"Aninat","year":"2006","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.toxrep.2015.03.006_bib0080","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jchromb.2005.04.008","article-title":"Fingerprint analysis of Psoralea corylifolia L. by HPLC and LC\u2013MS","volume":"821","author":"Zhao","year":"2005","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.toxrep.2015.03.006_bib0085","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1517\/17425255.2012.685159","article-title":"The HepaRG cell line: a unique in vitro tool for understanding drug metabolism and toxicology in human","volume":"8","author":"Andersson","year":"2012","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.toxrep.2015.03.006_bib0090","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s12272-010-0206-5","article-title":"Pharmacokinetics, tissue distribution and excretion of coumarin components from Psoralea corylifolia L. in rats","volume":"33","author":"Feng","year":"2010","journal-title":"Arch. Pharm. Res."},{"key":"10.1016\/j.toxrep.2015.03.006_bib0095","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.bcp.2013.05.015","article-title":"Drug-drug interactions and metabolism in cytochrome P450 2C knockout mice: application to troleandomycin and midazolam","volume":"86","author":"Grimsley","year":"2013","journal-title":"Biochem. Pharmacol."}],"container-title":["Toxicology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214750015000384?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214750015000384?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,22]],"date-time":"2019-08-22T23:26:53Z","timestamp":1566516413000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2214750015000384"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015]]},"references-count":19,"alternative-id":["S2214750015000384"],"URL":"https:\/\/doi.org\/10.1016\/j.toxrep.2015.03.006","relation":{},"ISSN":["2214-7500"],"issn-type":[{"value":"2214-7500","type":"print"}],"subject":[],"published":{"date-parts":[[2015]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CYP3A4 inhibition by Psoralea corylifolia and its major components in human recombinant enzyme, differentiated human hepatoma HuH-7 and HepaRG cells","name":"articletitle","label":"Article Title"},{"value":"Toxicology Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.toxrep.2015.03.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}